MargaretRosenfeldMD

PubMed

• Progression of Otologic and Nasal Symptoms in Primary Ciliary Dyskinesia Throughout Childhood.
  Isabelle Dagher, Adam J Kimple, Thomas W Ferkol, Scott D Sagel, Sharon D Dell
  OTO Open. 2025-02-21
• Real-world association between ivacaftor initiation and lung function variability: A registry study.
  Rhonda D Szczesniak, Eleni-Rosalina Andrinopoulou, Hancheng Li, Raksha Jain, Nicole Mayer-Hamblett
  Journal of Cystic Fibrosis. 2025-02-09
• Perspectives of Hispanic and Latinx Community Members on AI-Enabled mHealth Tools: Qualitative Focus Group Study.
  Stephanie A Kraft, Shaan Chopra, Miriana C Duran, Janet A Rojina, Abril Beretta
  Journal of Medical Internet Research. 2025-02-06

Journal Articles

• Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years  
  Sanders DB, Fink A, Mayer-Hamblett N, Schechter MS, Sawicki GS, Rosenfeld M, Flume PA, Morgan WJ, J Pediatr, 1/2/2015
• Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis  
  Emond MJ, Louie T, Emerson J, Zhao W, Mathias RA, Knowles MR, Wright FA, Rieder MJ, Tabor HK, Nickerson DA, Barnes KC; National Heart, Lung, and Blood Institute (NHLBI..., Nat Genet, 1/1/2012
• Appropriate Pediatric Spirometry Reference Equations and Interpretation  
  Pittman J, Rosenfeld, M, Pediatr Allergy Immunol Pulmonol, 1/1/2011
• Monitoring of Structure and Function in Early Cystic Fibrosis Lung Disease  
  Ranganathan S, Davis SD, Rosenfeld, M, Pediatr Allergy Immunol Pulmonol, 1/1/2011
• Clinical applications of pediatric pulmonary function testing-Introduction to the series  
  Rosenfeld M, Pediatr Allergy Immunol Pulmonol, 1/1/2011
• Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively?  
  Tiddens H, Donaldson SH, Rosenfeld, M, Pare PD, Pediatr Pulmonol, 1/1/2010
• Treggiari MM, Rosenfeld, M, Retsch-Bogart G, Gibson R, Ramsey B  
  Treggiari MM, Rosenfeld, M, Retsch-Bogart G, Gibson R, Ramsey B, Pediatric Pulmonology, 1/1/2007
• Effect of choice of reference equation on the analysis of pulmonary function in cystic fibrosis patients  
  Rosenfeld, M, Pepe MS, Emerson J, Longton G, FitzSimmons S, Pediatric Pulmonology, 1/1/2001
• Cleaning home nebulizers used by patients with cystic fibrosis: is rinsing with tap water enough?  
  Rosenfeld, M, Joy P, Nguyen CD, Burns J., Journal of Hospital Infection, 1/1/2001
• Aerosolized antibiotics for bacterial lower airway infections: principles, efficacy and pitfalls  
  Rosenfeld M, Cohen M, Ramsey B, Infectious Diseases in Clinical Practice, 1/1/1998
• Aerosolized antibiotics for bacterial lower airway infections: principles, efficacy and pitfalls  
  Rosenfeld M, Cohen M, Ramsey B, Clinical Pulmonary Medicine, 1/1/1997
• Join now to see all

Books/Book Chapters

• Diagnostic Techniques for the Pediatric Pulmonologist 
  Chapter: Reference equations 
  Stanojevic S, Rosenfeld MEditors: Davis S, Koumbourlis A, Eber E.Springer Verlag2013
• The Netter Collection of Medical Illustrations 
  Chapter: Cystic Fibrosis 
  Rosenfeld, MEditors: David Kaminsky.ElsevierEdition 2nd,2010
• The Netter Collection of Medical Illustrations 
  Chapter: Bronchiectasis 
  Rosenfeld, M2010
• Lung Biology in Health and Disease: Cystic Fibrosis 
  Chapter: Pulmonary Exacerbations 
  Sanders, DB and Rosenfeld, MEditors: JL Allen, HB Panitch, R Rubenstein.Informa Healthcare, New York2010
• Pediatric Respiratory Diseases 
  Chapter: Cystic Fibrosis: Respiratory Manifestations 
  Tiddens H, Rosenfeld, MEditors: Taussig L.2008
• Pediatric Pulmonary Function Testing 
  Chapter: Respiratory Mechanics 
  Page 20 - 33Davis S, Gappa M, Rosenfeld, MEditors: Hammer J, Eber E.Prog Respir Res, Kargar, Basel2005
• Cystic Fibrosis 
  Chapter: Respiratory System: Pediatrics 
  Page 204 - 218Marshall S, Rosenfeld, M, Ramsey B.Editors: Hodson ME, Geddes DM.Chapman and Hall Medical, London2000
• Join now to see all

Abstracts/Posters

• Accurate and Privacy Preserving Cough Sensing using a Low-Cost Microphone
  Larson E.C., Lee T, Liu S., Rosenfeld M, Patel S.N., Proceedings of the 13th ACM International Conference on Ubiquitous Computing, Beijing China, 1/17/2011

Lectures

• Clinical trials in infants and young children with CF: where are we heading? 
  Carmel, CA - 1/30/2016
• The expanding phenotype of OFD1 mutations: hemizygous loss-of-function mutations in two patients with primary ciliary dyskinesia 
  Bar Harbor, ME - 1/20/2016
• SpiroSmart, a novel mobile phone-based spirometer: Evaluation of Accuracy 
  Seattle, WA - 1/12/2016
• Successful Academic Careers 
  University of Washington - 1/8/2016
• Tooth decay risk factors for individuals with cystic fibrosis 
  1/1/2016
• Association of Palivizumab Use In CF Infants With Longitudinal Outcomes 
  1/1/2016
• Assessment and Treatment of Pulmonary Exacerbations in the CF Foundation Patient Registry 
  1/1/2016
• Long-term Safety and Efficacy of Ivacaftor in Pediatric Patients Aged 2-5 Years with CF and a CFTR Gating Mutation 
  1/1/2016
• Safety, Tolerability, and Pharmacodynamics of Combination Lumacaftor/Ivacaftor Therapy in Patients Aged 6-11 Yrs with CF Homozygous For the F508DEL-CFTR Mutation 
  1/1/2016
• Association of palivizumab with longitudinal outcomes in CF infants 
  Orlando, FL - 1/1/2016
• The CF Therapeutics Pipeline: Ushering in an era of great hope 
  Cystic Fibrosis Research Institute, Redwood City, CA - 1/31/2015
• Conditions overlapping with primary ciliary dyskinesia 
  Minneapolis, MN - 1/28/2015
• Digital health monitoring: Beyond heart rates and pedometers 
  Seattle, WA - 1/18/2015
• Early Lung Disease in CF- What works? 
  1/15/2015
• Cystic fibrosis in Children 
  1/15/2015
• Research, a straight path forward…or not! 
  1/15/2015
• Results of the KIWI trial of ivacaftor in 2 to 5 year olds with CF and gating mutations 
  Brussels, Belgium - 1/12/2015
• A case of Nocardiosis in a child with PCD 
  Minneopolis, MN - 1/1/2015
• Treatment Response to Ivacaftor in Clinical Practice: Analysis of the CF Foundation Patient Registry 
  Phoenix, AZ - 1/1/2015
• Continuity of Care During Transfer from Pediatric to Adult Cystic Fibrosis Care Centers in the United States 
  Phoenix, AZ - 1/1/2015
• Variation in the epithelial sodium channel gene SCNN1B is strongly associated with decline in lung function in the epic cystic fibrosis cohort 
  Pheonix, AZ - 1/1/2015
• Variants in NLRC4 and NAIP are associated with delay in chronic pseudomonas airway infection and improved FEV in children with CF 
  Pheonix, AZ - 1/1/2015
• Extended evaluation of Ivacaftor treatment in pediatric patients with cystic fibrosis and a CFTR gating mutation 
  Pheonix, AZ - 1/1/2015
• Patterns of Pseudomonas Aeruginosa infection in a contemporary CF birth cohort: Emergence and transition between stages of infection 
  Pheonix, AZ - 1/1/2015
• Treatment response to Ivacaftor in clinical practice: Analysis of the US CF Foundation patient registry 
  Pheonix, AZ - 1/1/2015
• Join now to see all

Other

• "Early CF Lung Disease," Roundtable discussion and video 
  
  Dallas, TX - 1/1/2012
• CF Clinical Research: an Update 
  Cystic Fibrosis Foundation Virtual Patient Education Day Webcast
  1/29/2005